| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a determination method of autosomal dominant polycystic kidney disease using an autosomal dominant polycystic kidney marker substance, and to provide a method for screening a drug that can be used for drastic therapy and prevention. <P>SOLUTION: Autosomal dominant polycystic kidney disease is determined by detecting or quantitatively determining a marker substance of autosomal dominant polycystic kidney disease (5-methyl-2-deoxycytidine, glucosamine, ectoine, 2-deoxycytidine, allantoate, o-hydroxybenzoic acid, phenaceturic acid, 3-phenylpropionic acid, decanoic acid, hydroxydecanoic acid, and the like), and comparing the obtained results with detection results or quantitative determination results of the marker substance of autosomal dominant polycystic kidney disease in a normal control blood sample. <P>COPYRIGHT: (C)2012,JPO&INPIT</p> |
